Single-Cell Transcriptomics from Flow Cytometry via Machine Learning

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating single cell transcriptomic profiles, such as scRNAseq, are prohibitively expensive, time-consuming, and low throughput, preventing their use in diagnostics, patient monitoring, and population-scale immune profiling, while conventional flow cytometry techniques capture only a subset of useful information.

Innovation Solution

A machine learning-based approach that combines flow cytometry with single cell RNA sequencing to predict single cell transcriptomic data from standardized flow cytometric immune profiling, using a trained machine learning model to generate detailed immune gene expression profiles from flow cytometry data.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If single cell RNA sequencing (scRNAseq) is used to generate single cell transcriptomic profiles, then measurement precision and resolution are improved, but cost, time consumption, and device complexity increase prohibitively

Engineering Contradiction:
Improvesingle cell transcriptomic resolutionVSAvoidsample processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent creates a computational copy of scRNAseq data by training a machine learning model on paired scRNAseq and flow cytometry datasets. The model learns to predict transcriptomic profiles from flow cytometry measurements, generating synthetic scRNAseq-like data without performing actual sequencing. This copying approach preserves measurement precision while eliminating the complexity and cost of physical sequencing infrastructure.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent replaces the physical mechanical process of RNA sequencing with a computational machine learning prediction system. Instead of using complex sequencing hardware and wet-lab processing, the system uses trained neural networks to transform flow cytometry data into transcriptomic profiles, substituting physical measurement with computational inference.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If single cell RNA sequencing (scRNAseq) is used to generate single cell transcriptomic profiles, then measurement precision is improved, but processing time and throughput are worsened

Engineering Contradiction:
Improvesingle cell transcriptomic resolutionVSAvoidsample processing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary action by pre-training the machine learning model on a comprehensive dataset of paired scRNAseq and flow cytometry measurements before actual use. This training phase captures the relationship between flow cytometry features and transcriptomic profiles, enabling rapid prediction during deployment without requiring time-consuming sequencing processes for each new sample.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system generates transcriptomic profiles as computational copies predicted from flow cytometry data, eliminating the need for time-consuming physical sequencing. The ML model instantiates transcriptomic information from surface protein measurements, achieving rapid profile generation while maintaining scientific accuracy.

Inventive Principle:
Principle #26Copying

3Productivity

If conventional flow cytometry is used for immune profiling, then productivity and cost-effectiveness are improved, but measurement precision and information completeness are worsened

Engineering Contradiction:
Improvesample processing throughputVSAvoidtranscriptomic information
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent introduces a machine learning model as an intermediary that bridges flow cytometry measurements and transcriptomic information. The model processes flow cytometry data (surface protein expressions) and transforms it into predicted transcriptomic profiles, mediating between the two measurement modalities to recover lost information while maintaining flow cytometry's productivity advantages.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system changes the parameter representation by transforming flow cytometry measurements (fluorescence intensity of surface proteins) into transcriptomic parameters (gene expression levels). The ML model learns the mapping between these different parameter spaces, enabling the system to work with flow cytometry's high-throughput data while outputting information in transcriptomic format.

Inventive Principle:
Principle #35Parameter changes

4Measurement precision

If single cell RNA sequencing (scRNAseq) is used to generate single cell transcriptomic profiles, then measurement precision is improved, but cost and scalability are worsened

Engineering Contradiction:
Improvesingle cell transcriptomic resolutionVSAvoidscalability to hundreds of samples
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent generates transcriptomic profiles as computational copies predicted from flow cytometry data, eliminating the need for expensive physical sequencing infrastructure. The ML model instantiates transcriptomic information from surface protein measurements, achieving scalable deployment across hundreds or thousands of samples without proportionally increasing cost.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The system replaces expensive wet-lab sequencing operations with computational prediction, substituting physical infrastructure costs with software processing. This substitution enables scaling to large sample sizes while maintaining cost-effectiveness, as computational resources are significantly cheaper than sequencing infrastructure.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS20250290843A1Methods and systems for predicting single cell transcriptomic information from flow cytometry data
Publication Date: 2025.09.18 MELIO HEALTHCARE LTD
  • US20250290843A1 patent drawing
  • US20250290843A1 patent drawing
  • US20250290843A1 patent drawing

AI summary

Method and systems for generating a single cell gene expression and/or clonality status profile for a subject from only flow cytometry data. Methods and systems for training a machine learning model to predict single cell gene expression and/or clonality status from flow cytometry and methods and systems to use the trained machine learning model to generate a single cell transcriptomic profile for a subject.